These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 753494)

  • 1. The effect of allopurinol on urinary oxalate excretion in stone formers.
    Scott R; Paterson PJ; Mathieson A; Smith M
    Br J Urol; 1978 Dec; 50(7):455-8. PubMed ID: 753494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in urinary oxalate values by allopurinol.
    Scott R; Paterson PJ; Smith M; Mathieson A
    Urology; 1978 Aug; 12(2):212-4. PubMed ID: 695155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of effect of allopurinol on oxalate excretion by stone patients on random and controlled diets.
    Urivetzky M; Braverman S; Motola JA; Smith AD
    J Urol; 1990 Jul; 144(1):97-8. PubMed ID: 2359187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of febuxostat versus allopurinol or placebo in individuals with higher urinary uric acid excretion and calcium stones.
    Goldfarb DS; MacDonald PA; Gunawardhana L; Chefo S; McLean L
    Clin J Am Soc Nephrol; 2013 Nov; 8(11):1960-7. PubMed ID: 23929928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine composition in patients with renal stone disease during treatment with allopurinol.
    Tiselius HG; Larsson L
    Scand J Urol Nephrol; 1980; 14(1):65-71. PubMed ID: 7375845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of calcium oxalate crystal growth in urine during treatment with allopurinol.
    Tiselius HG
    Br J Urol; 1980 Jun; 52(3):189-92. PubMed ID: 7426978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary oxalate levels are not affected by dietary purine intake or allopurinol.
    Morris GS; Simmonds HA; Toseland PA; Van Acker KJ; Davies PM; Stuchbury JH
    Br J Urol; 1987 Oct; 60(4):292-300. PubMed ID: 3690198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical relationship between urine composition and urinary stone formation in stone forming patients.
    Abdel-Aziz AF; el-Waseef A; Abou el-Fotouh M
    Int Urol Nephrol; 1996; 28(4):457-64. PubMed ID: 9119628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allopurinol in the recurrence prevention of calcium oxalate lithiasis.
    Brien G; Bick C
    Eur Urol; 1977; 3(1):35-6. PubMed ID: 837952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary risk factors in calcium oxalate stone disease: comparison of men and women.
    Ryall RL; Harnett RM; Hibberd CM; Mazzachi BC; Mazzachi RD; Marshall VR
    Br J Urol; 1987 Dec; 60(6):480-8. PubMed ID: 3427328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies of urinary risk factors in urolithiasis].
    Ebisuno S; Kitagawa M; Morimoto S; Miyazaki Y; Minakata S; Yasukawa S; Fukatani T; Ohkawa T
    Hinyokika Kiyo; 1985 Jan; 31(1):1-15. PubMed ID: 3993484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oxalate loading test for outpatients with calcium oxalate stones].
    Kato M
    Hinyokika Kiyo; 1986 Mar; 32(3):351-60. PubMed ID: 3728240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary oxalate in summer and winter in normal subjects and in stone-forming patients with idiopathic hypercalciuria, both untreated and treated with thiazide and/or cellulose phosphate.
    Hallson PC; Kasidas GP; Rose GA
    Urol Res; 1976; 4(4):169-73. PubMed ID: 1020068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of recurrent uric acid and calcium oxalate stones by administration of the xanthine oxidase inhibitors Milurit 100 and Milurit 300.
    Schneider HJ; Brundig P; Balogh A; Traeger A; Stein G; Fünfstück R
    Int Urol Nephrol; 1983; 15(2):121-9. PubMed ID: 6688800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in urinary composition of calcium oxalate stone formers.
    Rahman B; Rahman MA
    Biomed Pharmacother; 1986; 40(3):108-10. PubMed ID: 3742009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of gout and urate calculi with allopurinol.
    O'Duffy JD; Scherbel AL
    Cleve Clin Q; 1968 Jul; 35(3):145-54. PubMed ID: 5757545
    [No Abstract]   [Full Text] [Related]  

  • 19. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate.
    Troxel SA; Sidhu H; Kaul P; Low RK
    J Endourol; 2003 Apr; 17(3):173-6. PubMed ID: 12803990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute acid load in recurrent oxalate stone formers.
    Knispel HH; Fitzner R; Kaiser M; Butz M
    Urol Int; 1988; 43(2):93-6. PubMed ID: 3388639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.